Baicalein also reversed epithelial-mesenchymal transition (EMT), a key process in metastasis, where Chen et al. [82] demonstrated that baicalein delayed tumor progression, reduced metastasis, and prolonged survival in a breast cancer mouse model by suppressing calpain-2 activity and modulating Ca2+ levels and ERK signaling. This evidence concerns the gene CAPN2 and breast carcinoma.